Does RISANKIZUMAB-RZAA Cause Platelet count abnormal? 7 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Platelet count abnormal have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
7
Reports of Platelet count abnormal with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
1
Deaths
4
Hospitalizations
How Dangerous Is Platelet count abnormal From RISANKIZUMAB-RZAA?
Of the 7 reports, 1 (14.3%) resulted in death, 4 (57.1%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Platelet count abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Platelet count abnormal?
RUXOLITINIB (786)
ROMIPLOSTIM (703)
ELTROMBOPAG OLAMINE (370)
ECULIZUMAB (261)
LENALIDOMIDE (216)
RITUXIMAB (181)
VENETOCLAX (178)
IBRUTINIB (176)
DEXAMETHASONE (128)
NIRAPARIB (112)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Platelet count abnormal Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA